Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links.
Rudic
R D
RD
Yale University School of Medicine, Department of Pharmacology, Molecular Cardiobiology Division, Boyer Center for Molecular Medicine, New Haven, Connecticut, USA. willaim.sessa@yale.edu http://www.journals.uchicago.edu/cgi-bin/resol.
Sessa
W C
WC
D000818:Animals; D001161:Arteriosclerosis / Q000378:metabolism / Q000503:physiopathology; D002342:Carotid Artery, External / Q000378:metabolism; D004730:Endothelium, Vascular / Q000502:physiology* / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000378:metabolism / Q000503:physiopathology; D051379:Mice; D018345:Mice, Knockout; D008957:Models, Genetic; D019331:NG-Nitroarginine Methyl Ester / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000235:genetics / Q000378:metabolism; D051381:Rats; D014665:Vasodilator Agents / Q000494:pharmacology
D014665:Vasodilator Agents; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D019331:NG-Nitroarginine Methyl Ester